Charles Schwab Investment Management Inc Codex Dna, Inc. Transaction History

Charles Schwab Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.8 - $6.45 $46,683 - $167,280	-25,935 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.12 - $10.36 $42,559 - $107,018	10,330 Added 66.2%	25,935 $140,000
Q3 2021 Nov 16, 2021	BUY	$10.15 - $19.88 $158,390 - $310,227	15,605 New	15,605 $174,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.